Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Apex MD vs Maves

Apex MD
Graded #87

Level

vs
Maves
Graded #88

Level

The verdict

Too close to call — both grade 71.8/100 (C).

Apex MD and Maves land on the same WeighScore, so neither clears the other on our six graded dimensions. Apex MD sits one line higher on the board (#87 vs #88) on the underlying tiebreak, but it's a genuine coin-flip — pick on the factors and prices that matter most to you below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueMaves +36
48
84
Dose & formulationApex MD +18
83
65
Clinical oversightApex MD +2
78
76
Labs & monitoringApex MD +37
89
52
FulfillmentMaves +5
82
87
Contract termsEven
55
55
Apex MD · left barMaves · right bar

The numbers

MetricApex MDMaves
WeighScore71.8/10071.8/100
GradeCC
Scorecard rank#87#88
Semaglutide$299/mo$99/mo (starting dose, first-month rate, compounded)
Tirzepatide$399/moNot disclosed
CoverageAll 50 statesAll 50 states
Brand-name accessCompounded onlyYes
Oral / sublingualYesInjection only
Apex MD

Graded #87 · C

Strengths

  • Licensed in all 50 states
  • Unlimited provider visits and Labcorp labs included in the plan
  • Both semaglutide and tirzepatide, injectable or oral
  • Medication delivery typically in under four business days

Where it loses points

  • Compounds bundle NAD, B-12 and L-Carnitine rather than a single-ingredient GLP-1
  • Does not publicly name its compounding pharmacy or list an accreditation seal
Maves

Graded #88 · C

Strengths

  • LegitScript Certified
  • Publishes the FDA compounded-medication disclaimer
  • $99/mo first-month intro pricing on semaglutide — among the most aggressive we track
  • All 50 states covered, stated explicitly
  • Both brand (Maves) and parent (Homera Health) disclosed for accountability

Where it loses points

  • 503A pharmacy partner not named (only 'licensed U.S. pharmacies')
  • Tirzepatide pricing not stated on the homepage — only listed as an offering
  • Named medical director / clinical leadership not disclosed
  • Refund and cancellation policy not detailed publicly
  • Corporate address and arbitration venue not disclosed

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard